News
Alexion to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
Alexion Pharmaceuticals, Inc announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday,...
Press Releases
Successful ExCeL debut for Infrarail and CITE 2016
With unprecedented levels of rail investment and the rise of national infrastructure up the political agenda, there was an upbeat mood at the Infrarail...
Research Insight
Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of Improving Overall Survival
Bayer announced that a Phase III trial evaluating its oncology compound regorafenib (Stivarga®) for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has...
Press Releases
Reed Sinopharm Hosts World’s Largest Healthcare Event – tHIS in Shanghai
SHANGHAI, April 21, 2016 /PRNewswire/ -- The Health Industry Summit (tHIS) 2016 opened in Shanghai at the National Exhibition and Convention Center on April 17....
Press Releases
AstraZeneca completes divestment of Imdur to China Medical System Holdings
AstraZeneca announced that it has completed the divestment of the global rights to Imdur, outside the US, to China Medical System Holdings Ltd and...
Industry Reports
AstraZeneca acquired Takedas respiratory business
AstraZeneca announced that it has completed the acquisition of the core respiratory business of Takeda Pharmaceutical Company Limited . The agreement, announced in December...
News
AbbVie to Acquisition of Stemcentrx and its Novel
AbbVie a global biopharmaceutical company, announced that it will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T) currently in registrational trials...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read